Cancer Risk With Topical Immunosuppressants Subject Of Pediatric Advisory Cmte. Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
Risk management strategies, including evaluation and communication, will be discussed at the Feb. 15 meeting. The advisory committee will also meet Feb. 14 to hear pediatric adverse event updates for several drugs.